The peptide was originally isolated from gastric juice and demonstrates protective effects on digestive tissue in animal studies
King A, Tan X, Dhopeshwarkar N, Bohn R, Dea K, Leonard CE et al
10.1016/j.neuroscience.2012.10.019 Neuroscience 113 LunenfeldB.BilgerW.LongobardiS.KirstenJ.DhoogheT.SunkaraS
Slowed gastric emptying (the stomach) causes nausea, early satiety, and reflux
The Fat Loss Mechanism The proposed fat loss mechanism of 5-amino-1MQ operates through several interrelated effects: NNMT inhibition preserves SAM and NAD+ pools Increased NAD+ supports sirtuin activity and mitochondrial function Reduced lipogenesis adipocyte fatty acid synthesis is decreased Enhanced adipocyte metabolism improved adipose tissue function Selective effect on adipocytes relative sparing of other tissues Preclinical studies have shown that 5-amino-1MQ treatment in mice produces: Reduced body fat mass Improved insulin sensitivity Preserved lean mass Favorable effects on liver fat in diet-induced obesity models The Human Clinical Trials Picture As of 2026, human clinical trial activity for 5-amino-1MQ is emerging but not yet mature
Can semaglutide cause an injection site reaction